売上原価、Research And Development Expenses Research And Development Activities - Spe Reportable Segments Member、Provision Of General ReserveREBF他2件
- 【期間】
| 年度 | 売上原価 | Research And Development Expenses Research And Development Activities - Spe Reportable Segments Member | Provision Of General ReserveREBF | その他の流動負債の増減額（△は減少） | Ending Finished GoodsCOS |
|---|
| 2010/09 | 783億 | | - | | - | | 18.1億 | | - | |
| 2011/09 | 901億 | +15.2% | - | | - | | -26.7億 | 赤転 | - | |
| 2012/09 | 758億 | -15.9% | - | | - | | -16.8億 | 赤縮 | - | |
| 2013/09 | 845億 | +11.5% | - | | - | | 31.1億 | 黒転 | - | |
| 2014/09 | 795億 | -6% | - | | - | | -32.2億 | 赤転 | - | |
| 2015/09 | 904億 | +13.7% | - | | - | | 6.43億 | 黒転 | - | |
| 2016/09 | 950億 | +5.1% | - | | - | | 95.2億 | 大幅増 | - | |
| 2017/09 | 1053億 | +10.9% | - | | - | | 24.4億 | -74.3% | - | |
| 2018/09 | 1205億 | +14.4% | - | | - | | 22.7億 | -7.1% | - | |
| 2019/09 | 1131億 | -6.2% | - | | - | | -18.2億 | 赤転 | - | |
| 2020/09 | 1055億 | -6.7% | - | | - | | 31.4億 | 黒転 | - | |
| 2021/09 | 1292億 | +22.5% | - | | - | | 33億 | +5.1% | - | |
| 2022/09 | 1422億 | +10.1% | - | | - | | 2.5億 | -92.4% | - | |
| 2023/09 | 1427億 | +0.3% | - | | - | | 106億 | 大幅増 | - | |
| 2024/09 | 1704億 | +19.4% | - | | - | | -19.6億 | 赤転 | - | |
